Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Enrolling by Invitation

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

NCT01511393

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +18 more
Locations: United BioSource, LLC Morgantown, West Virginia, United States

View Trial Details

Enrolling by Invitation

A Prospective Cohort Study for Patients With Adrenal Diseases

NCT03474237

Conditions: ACTH Syndrome, Ectopic, Adenocarcinoma, Adrenal Adenoma, +26 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Not Yet Recruiting

Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.

NCT07340619

Conditions: Melanoma, Metastatic (Stage IV) Melanoma, Neoplasm Metastasis, +14 more
Locations: Institut Bergonie Bordeaux, France

Centre Leon Berard Lyon, France

Institut Paoli Calmettes Marseille, France

Centre Antoine Lacassagne Nice, France

View Trial Details

Not Yet Recruiting

Clinical Genetics Branch Eligibility Screening Survey

NCT07005297

Conditions: Abnormalities, Multiple, Anemia, Anemia, Aplastic, +44 more
Locations: National Cancer Institute Rockville, Maryland, United States

View Trial Details

Not Yet Recruiting

A Comparative Usability Study of Two Total Body Skin Imaging Systems

NCT07740642

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: University Hospital Basel Basel, Canton of Basel-City, Switzerland

View Trial Details

Not Yet Recruiting

NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

NCT07740941

Conditions: Melanoma, Melanoma (Skin Cancer), Melanoma Stage IV, +13 more
Locations: Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

View Trial Details

Not Yet Recruiting

MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

NCT07574047

Conditions: Advanced Melanoma, Melanoma, Neoplasms, +10 more
Locations: HFR Fribourg Fribourg, Canton of Fribourg, Switzerland

Ente Ospedaliero Cantonale (EOC) Bellinzona, Switzerland

Inselspital, Bern Bern, Switzerland

Hôpitaux Universitaires de Genève HUG Geneva, Switzerland

View Trial Details

Not Yet Recruiting

TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors

NCT07713732

Conditions: Adenocarcinoma, Adenoma, Bronchial Neoplasms, +33 more
Locations: COBL Clinical Trials - Chris O'Brien Lifehouse Camperdown, New South Wales, Australia

Cabrini Hospital Malvern Malvern, Victoria, Australia

Linear Clinical Research Nedlands, Western Australia, Australia

View Trial Details

Not Yet Recruiting

A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

NCT07689812

Conditions: Adenocarcinoma, Advanced Solid Tumors, Advanced Solid Tumors Cancer, +54 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1

NCT07472322

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
Locations: University of Wisconsin-Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details